Companies / Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

Nasdaq: LSTACIK 320017BASKING RIDGE, NJcaladrius.com

Financials · FY2024

Revenue$170.0K
Net income$-16.59M
Total debt$0
Cash$10.44M
Diluted EPS$-1.91
Shares outstanding9.0M

Ownership

9.0M shares outstanding · as of Aug 6, 2026
10.6%Insiders
Ownership
Insiders10.56%951,311
Institutions10.04%904,604
Public float79.40%7,155,022

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Mazzo David JCEOPresident & CEO · Director
3.46%311,890
1.16%104,925
1.06%95,815
1.06%95,659
1.06%95,446
Buck Kristen KEVP, R&D and CMO
1.04%93,462
Henson HeidiDirector
0.95%85,725
Imam TariqSVP, Bus Dev, General Counsel
0.40%36,078
Nisco JamesSVP, Fin/Treas, Chief Actg Off
0.36%32,311

Institutional holders 30

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 9, 2026Mazzo David J
CEO
OtherCommon Stock$24.1K-12K
-3.68%
319,744
3.55% of shares
low
Jan 9, 2026Mazzo David J
CEO
OtherCommon Stock$20.7K-11K
-3.07%
331,968
3.68% of shares
low
Jan 9, 2026Mazzo David J
CEO
OtherCommon Stock$20.7K-11K
-2.98%
342,483
3.80% of shares
low
Jan 9, 2026Mazzo David J
CEO
OtherCommon Stock$15.5K-8K
-2.46%
311,890
3.46% of shares
low
Jan 9, 2026Buck Kristen K
Executive
OtherCommon Stock$6.3K-3K
-3.26%
95,609
1.06% of shares
low
Jan 9, 2026Buck Kristen K
Executive
OtherCommon Stock$5.9K-3K
-2.93%
98,830
1.10% of shares
low
Jan 9, 2026Buck Kristen K
Executive
OtherCommon Stock$5.9K-3K
-2.85%
101,812
1.13% of shares
low
Jan 9, 2026Buck Kristen K
Executive
OtherCommon Stock$4.2K-2K
-2.25%
93,462
1.04% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LSTACommon StockEquity128058302BBG000BNVDR4